If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched ...

"Donald Trump's shocking press conference exit sparks viral health speculation. What really happened? #TrumpHealthMystery" ...

Sanofi (NASDAQ:SNY) announced on Tuesday that it has stopped supplying Praluent in China due to limited availability of the ...

Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...

Regeneron Pharmaceuticals, Inc. saw a significant boost this quarter, with Mitsubishi UFJ Asset Management Co. Ltd. upping ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Regeneron Pharmaceuticals, Inc.

Shares of Regeneron Pharmaceuticals Inc. slipped 3.03% to $545.94 Monday, on what proved to be an all-around poor trading ...

Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...

Regeneron Court Permits Government to Pursue False Certification Theory - On August 4, the district court in the closely ...

Our Health Care Litigation Team discusses a District of Massachusetts case holding that allows the government to switch liability theories in ...

Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

At this year's Regeneron International Science and Engineering Fair in Columbus, judges awarded the George D. Yancopoulos Innovator Award to Kovalčík, whose drug production method — as Business ...